Haryana Bans High-Dose Nimesulide Oral Formulations

The Haryana government has banned the manufacture, sale, and distribution of Nimesulide in oral immediate release formulations above 100 mg.

This decision was made to protect public health, as scientific evidence indicates that high doses of Nimesulide can be harmful.

The government has directed drug manufacturers, wholesalers, retailers, and chemists to comply with the ban and has advised doctors to prescribe safer alternatives.

Regular inspections will be carried out to ensure compliance, and strict action will be taken against violators.

The ban follows a notification issued by the Government of India after consultation with the Drugs Technical Advisory Board.